U.S. flag

An official website of the United States government

Filters

See more specimen types...
See more states

Other countries

See more countries

Results: 1 to 20 of 137

Tests names and labsConditionsGenes, analytes, and microbesMethods

SmartMeds+ Pharmacogenomic Testing By Innovative GX Health

Innovative Genomics InnovativeGx Health
United States
167
  • T Targeted variant analysis

PGx - Orthopedic Panel

Genesys Diagnostics Genesys Diagnostics, Inc.
United States
112
  • T Targeted variant analysis

PGx - Cardiovascular Panel

Genesys Diagnostics Genesys Diagnostics, Inc.
United States
111
  • T Targeted variant analysis

PGx - Pain Management Panel

Genesys Diagnostics Genesys Diagnostics, Inc.
United States
112
  • T Targeted variant analysis

PGx - Comprehensive Panel

Genesys Diagnostics Genesys Diagnostics, Inc.
United States
120
  • T Targeted variant analysis

F2 Gene Factor II deficiency NGS Genetic DNA Test

DNA Labs India
India
11
  • S Mutation scanning of the entire coding region

F2 Gene Thrombophilia due to thrombin defect NGS Genetic DNA Test

DNA Labs India
India
11
  • S Mutation scanning of the entire coding region

F2 Gene Dysprothrombinemia NGS Genetic DNA Test

DNA Labs India
India
11
  • S Mutation scanning of the entire coding region

Gravity Pharmacogenetics Comprehensive Profile

Gravity Diagnostics
United States
8617
  • T Targeted variant analysis

Genetic study of pharmacogenetics

HeartGenetics, Genetics and Biotechnology, SA
Portugal
126
  • T Targeted variant analysis

F2 Gene, Full Gene Next-Generation Sequencing

Mayo Clinic Laboratories Mayo Clinic
United States
11
  • C Sequence analysis of the entire coding region

Genetic Study of Hereditary Thrombophilia (11 genes, 15 variants)

HeartGenetics, Genetics and Biotechnology, SA
Portugal
111
  • E Sequence analysis of select exons
  • T Targeted variant analysis

Prothrombin

Center for Genetics at Saint Francis Saint Francis Hospital
United States
11
  • T Targeted variant analysis

Invitae Surgical Risk Screen

Invitae
United States
248
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

CARDIOpgx

Eugenomic S.L.
Spain
116
  • T Targeted variant analysis

GLOBALpgx

Eugenomic S.L.
Spain
121
  • T Targeted variant analysis

F2 - NGS including CNV analysis

Centogene AG - the Rare Disease Company
Germany
41
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

CentoNeuro Panel

Centogene AG - the Rare Disease Company
Germany
18861858
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Epilepsy Panel

Centogene AG - the Rare Disease Company
Germany
734744
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

CentoIEM Panel

Centogene AG - the Rare Disease Company
Germany
669688
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Results: 1 to 20 of 137

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.